Clinical Trial Update: Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase I trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of multiple IV doses of PF-04236921 in patients with rheumatoid arthritis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PF-04236921

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2018-11-02